Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Intermediate Layer-Engineered Lanthanide Nanoparticles Enable Deep Bioorthogonal Liver Tumor and Vascular Imaging via Switchable NIR-II Emissions.

Created on 23 May 2025

Authors

Kehong Lv, Hongxia Yue, Chunyan Li, Shengzhe Chen, Hongli Wang, Ruohao Zhang, Jing Feng, Hongjie Zhang

Published in

Angewandte Chemie (International ed. in English). Pages e202507787. May 23, 2025. Epub May 23, 2025.

Abstract

The second near-infrared window (NIR-II) has become an attractive optical region for fluorescence imaging. However, due to the complexity in vivo, NIR-II light with various wavelengths for different imaging sences has not been investigated. Here, we found that 1525 nm light is suitable for high-resolution fluorescence imaging due to low background interference, while its attenuation in vivo makes it unsuitable for deep imaging. The 1064 nm light is suitable for deep imaging. The impact of Yb3+ ions and the proportion of the intermediate layer in lanthanide nanoparticles on the modulation of emissions were investigated. The intense 1064 nm emission is achievable when the Yb3+ content is 80% and the intermediate layer proportion is 0.1. The bioorthogonal orthotopic liver tumor imaging could be achieved by modifying the lanthanide nanoparticles with DBCO-PEG2000-DSPE and establishing artificial receptors by N-azidoacetylmannosamine-tetraacylated (Ac4ManNAz). Lanthanide nanoparticles with the intermediate layer proportion of 0.66 and 80% Yb3+ facilitate intense 1525 nm emission, enabling the vascular imaging. Based on the imaging characteristics of NIR-II emissions with different wavelengths in vivo, this work achieves high-resolution imaging and deep imaging through intermediate layer regulation of lanthanide nanoparticles, providing an opportunity to explore a new generation of high-performance fluorescent probes.

PMID:
40406815
Bibliographic data and abstract were imported from PubMed on 23 May 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 22
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement